Generic Name: Ranitidine hydrochloride
Product Name: Zantac
The use of Ranitidine is indicated in the following conditions:
- Peptic ulcer disease
- Gastro-oesophageal reflux disease
Zantac belongs to a class of drugs called histamine receptor antagonists. Its active ingredient, Ranitidine, works by decreasing the amount of acid the stomach produces.
Peptic Ulcer Disease:
- The initial recommended dose is 300 mg orally given as a single evening dose for 4–8 weeks or 50 mg intravenously or intramuscularly given every 6–8 hours.
- Maintenance dosing is 150–300 mg orally given as a single evening dose.
Gastro-Oesophageal Reflux Disease:
- 300 mg orally given as a single evening dose
Prevention of stress ulcer:
- The initial dose is 50 mg intravenously given slowly
- An intravenous infusion of 125–250 micrograms/kg/hour should be continued until risk factors for stress ulcer are removed.
- 150 mg orally twice a day for 4–8 weeks.
- 2–4 mg/kg orally twice daily up to a maximum dose of 300 mg a day. 1 mg/kg intravenously every 6–8 hours up to a maximum dose of 50 mg.
Common side effects
Uncommon side effects
- Development of breast tissue in males
- Decreased libido
- Reversible involuntary movement
For further information talk to your doctor.